Garlic Sugar Coated Tablets

Kraj: Wielka Brytania

Język: angielski

Źródło: VMD (Veterinary Medicines Directorate)

Składnik aktywny:

Garlic, Garlic Oil

Dostępny od:

Dorwest Herbs Limited

INN (International Nazwa):

Garlic, Garlic Oil

Forma farmaceutyczna:

Coated tablet

Typ recepty:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Grupa terapeutyczna:

Cats, Dogs

Dziedzina terapeutyczna:

Herbal

Status autoryzacji:

Expired

Data autoryzacji:

1997-09-01

Charakterystyka produktu

Revised: December 2019
AN: 01138/2019
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Garlic Sugar Coated Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substances: Each tablet contains;
Garlic ( Powdered) 30mg
Oil of Garlic 0.001ml
Excipients:
Titanium dioxide (E171) 0.15mg
For full list of excipients see section 6.1
3. PHARMACEUTICAL FORM
Coated tablet
White sugar coated tablet, 8.73mm diameter
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs and cats
4.2
INDICATIONS FOR USE
A herbal medicine for the symptomatic relief of coughs and bronchial
conditions, and an aid to
maintaining general health in dogs and cats.
4.3
CONTRA-INDICATIONS
None
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Dogs – None necessary
Cats – None necessary
Revised: December 2019
AN: 01138/2019
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
i) Special precautions for use in animals:
If condition fails to improve within 7 days, consult a veterinary
surgeon
ii) Special precautions to be taken by the person administering the
medicinal product to
animals:
Wash hands after use
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Based on post marketing experience and complementary data, emesis has
been observed
very rarely.
The frequency of adverse reactions is defined using the following
convention:
- very common (more than 1 in 10 animals treated displaying adverse
reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals
treated)
- rare (more than 1 but less than 10 animals in 10,000 animals
treated)
- very rare (less than 1 animal in 10,000 animals treated, including
isolated reports).
4.7
USE DURING PREGNANCY AND LACTATION
Normal use, no restrictions
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
1 tablet per 5kgs bodyweight daily
Oral administration
4.10
OVERDOSE
No treatment specified
4.11
WITHDRAWAL PE